Correlation Between Cannara Biotech and Flowr Corp

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Flowr Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Flowr Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and Flowr Corp, you can compare the effects of market volatilities on Cannara Biotech and Flowr Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Flowr Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Flowr Corp.

Diversification Opportunities for Cannara Biotech and Flowr Corp

0.0

Correlation Coefficient

Cannara Biotech  Flowr Corp

Pay attention - limited upside

The 3 months correlation between Cannara and Flowr is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Flowr Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Flowr Corp and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Flowr Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Flowr Corp has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Flowr Corp go up and down completely randomly.

Pair Corralation between Cannara Biotech and Flowr Corp

Assuming the 90 days horizon Cannara Biotech is expected to generate 169.97 times less return on investment than Flowr Corp. But when comparing it to its historical volatility, Cannara Biotech is 21.99 times less risky than Flowr Corp. It trades about 0.01 of its potential returns per unit of risk. Flowr Corp is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  1.90  in Flowr Corp on September 29, 2024 and sell it today you would lose (1.90) from holding Flowr Corp or give up 100.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	82.66%
Values	Daily Returns

Cannara Biotech  vs.  Flowr Corp

Cannara Biotech

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Flowr Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Flowr Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Flowr Corp is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Cannara Biotech and Flowr Corp

The main advantage of trading using opposite Cannara Biotech and Flowr Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Flowr Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Flowr Corp will offset losses from the drop in Flowr Corp's long position.

The idea behind Cannara Biotech and Flowr Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.